Ascend Capital’s Colgate-Palmolive CL Stock Holding History

Ascend Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-75,700	Closed	-$5.71M	–	214
2017 Q4	$5.71M	Buy	+75,700	New	+$5.53M	0.21%	112

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ascend Capital's CL Position: Q1 2018 in Review

Ascend Capital sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 75,700 shares — an estimated $5.71M sold.

Ascend Capital first reported a position in CL in Q4 2017 and held it in 1 quarter. The position peaked at $5.71M in Q4 2017. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

Ascend Capital reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
Ascend Capital sold 75,700 Colgate-Palmolive shares in Q1 2018, an estimated $5.71M.
Ascend Capital first reported a position in Colgate-Palmolive in Q4 2017 and held it in 1 quarter.
Ascend Capital's Colgate-Palmolive position peaked at $5.71M in Q4 2017.
1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.